Innovation at the Interface of Academia and Industry
The USC Institute for Biomedical Therapeutics is also capable of taking these new discoveries and advancing them towards translation through collaborative development with industry. Built on the National Science Foundation-funded Biomimetic Micro-Electronic Systems (BMES) Engineering Research Center at USC (2003-2013), the Institute leverages a decade of international industrial collaboration with eight other universities, 17 industry partners and six national laboratories.
The foundation of academic and industrial collaboration laid by BMES and integrated into The USC IBT has been effective in driving new technology translation. Over ten years, approximately $14 million in additional collaborative grants and sponsored programs have been captured; 197 patents have been filed; 25 licensing agreements have been issued; and nine new start-up companies have been founded. The USC Institute for Biomedical Therapeutics aims to continue its best practices to effectively drive new technologies to the clinic.
The relationship between USC IBT and its partners propels research forward, bringing us one step closer to translating our basic science discoveries into real clinical applications.
⋅ Approximately $14 million in additional collaborative grants and sponsored programs have been captured.
⋅ 199 patents have been filed
⋅ 25 licensing agreements have been issued
⋅ 10 new start-up companies have been founded
An Institute without Borders
Our multidisciplinary initiatives extend to over 40 locations worldwide.